Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

343.50p
   
  • Change Today:
    -2.50p
  • 52 Week High: 445.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 106.09m
  • Volume: 80,074
  • Market Cap: £364.43m
  • RiskGrade: 125
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
78.58% above the market average78.58% above the market average78.58% above the market average78.58% above the market average78.58% above the market average
51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
7.80% above the market average7.80% above the market average7.80% above the market average7.80% above the market average7.80% above the market average
12% below the sector average12% below the sector average12% below the sector average12% below the sector average12% below the sector average
Price Book Ratio
84.89% below the market average84.89% below the market average84.89% below the market average84.89% below the market average84.89% below the market average
42.11% below the sector average42.11% below the sector average42.11% below the sector average42.11% below the sector average42.11% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
82.13% above the market average82.13% above the market average82.13% above the market average82.13% above the market average82.13% above the market average
82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average
Price Chg 3m
52.25% above the market average52.25% above the market average52.25% above the market average52.25% above the market average52.25% above the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
67.78% above the market average67.78% above the market average67.78% above the market average67.78% above the market average67.78% above the market average
85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average
Momentum 20
85.34% above the market average85.34% above the market average85.34% above the market average85.34% above the market average85.34% above the market average
76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
64.41% below the market average64.41% below the market average64.41% below the market average64.41% below the market average64.41% below the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
96% below the market average96% below the market average96% below the market average96% below the market average96% below the market average
95.56% below the sector average95.56% below the sector average95.56% below the sector average95.56% below the sector average95.56% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
28.32% above the market average28.32% above the market average28.32% above the market average28.32% above the market average28.32% above the market average
48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average
Operating Profit Loss
95% below the market average95% below the market average95% below the market average95% below the market average95% below the market average
91.11% below the sector average91.11% below the sector average91.11% below the sector average91.11% below the sector average91.11% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
47.00% above the market average47.00% above the market average47.00% above the market average47.00% above the market average47.00% above the market average
54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average
Cash
58.13% above the market average58.13% above the market average58.13% above the market average58.13% above the market average58.13% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Brokers Percent Neutral
40.12% above the market average40.12% above the market average40.12% above the market average40.12% above the market average40.12% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 343.50p
Change Today -2.50p
% Change -0.72 %
52 Week High 445.00
52 Week Low 232.50
Volume 80,074
Shares Issued 106.09m
Market Cap £364.43m
Beta 0.00
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.29% below the market average32.29% below the market average32.29% below the market average32.29% below the market average32.29% below the market average
21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average
Price Trend
32.66% below the market average32.66% below the market average32.66% below the market average32.66% below the market average32.66% below the market average
Sector averageSector averageSector averageSector averageSector average
Income Not Available
Growth
3.53% above the market average3.53% above the market average3.53% above the market average3.53% above the market average3.53% above the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 06-Jun-2025

Time Volume / Share Price
17:07 5,700 @ 343.50p
16:35 20,809 @ 343.50p
16:35 58 @ 343.50p
16:35 382 @ 343.50p
16:35 72 @ 343.50p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page